Pflug Koory, LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,197 filers reported holding NOVARTIS A G in Q3 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
Pflug Koory, LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$56,023
+0.9%
5500.0%0.03%
+14.3%
Q2 2023$55,501
+9.7%
5500.0%0.03%0.0%
Q1 2023$50,600
+101100.0%
5500.0%0.03%0.0%
Q4 2022$50
-99.9%
5500.0%0.03%
+7.7%
Q3 2022$42,000
-8.7%
5500.0%0.03%
-3.7%
Q2 2022$46,000
-4.2%
5500.0%0.03%
+12.5%
Q1 2022$48,000
-12.7%
550
-12.0%
0.02%
-14.3%
Q4 2021$55,000
+7.8%
6250.0%0.03%0.0%
Q3 2021$51,000
-31.1%
625
-22.8%
0.03%
-28.2%
Q2 2021$74,000
+21.3%
810
+14.1%
0.04%
+14.7%
Q1 2021$61,000
+32.6%
710
+46.4%
0.03%
+25.9%
Q4 2020$46,000
+9.5%
4850.0%0.03%
-3.6%
Q3 2020$42,000
+13.5%
485
+15.5%
0.03%
+3.7%
Q2 2020$37,000
+5.7%
4200.0%0.03%
-12.9%
Q1 2020$35,000
-14.6%
420
-3.0%
0.03%
+6.9%
Q4 2019$41,000
+7.9%
4330.0%0.03%0.0%
Q3 2019$38,000
-5.0%
4330.0%0.03%
-6.5%
Q2 2019$40,000
-4.8%
4330.0%0.03%
-6.1%
Q1 2019$42,000
+13.5%
4330.0%0.03%
+3.1%
Q4 2018$37,0000.0%4330.0%0.03%
+6.7%
Q3 2018$37,000
+12.1%
4330.0%0.03%
+15.4%
Q2 2018$33,000
-5.7%
4330.0%0.03%
-10.3%
Q1 2018$35,000
-2.8%
4330.0%0.03%
+3.6%
Q4 2017$36,000
-2.7%
4330.0%0.03%
-6.7%
Q3 2017$37,000
+2.8%
4330.0%0.03%0.0%
Q2 2017$36,000
+12.5%
4330.0%0.03%
+7.1%
Q1 2017$32,0000.0%4330.0%0.03%0.0%
Q4 2016$32,0004330.03%
Other shareholders
NOVARTIS A G shareholders Q3 2023
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders